News

The aerosol foam formulation of the fixed combination of calcipotriene and betamethasone dipropionate 0.005%/0.064%, has been developed to improve treatment for patients with plaque psoriasis. The NDA is

The injection is designed to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system (CNS). Previously, gadavist was approved for

The company also secured final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for this product, which is indicated to

The transaction also includes intellectual property and a technology platform related to a second, undisclosed vaccine program. CMV is a herpes virus and one out of every five

AQX-1125 is a small molecule activator of SHIP1, which is a regulating component of the PI3K cellular signaling pathway. The randomized, double-blind, multicenter, placebo-controlled Phase II KINSHIP trial

The randomized, double-blind, placebo-controlled Phase Ib trial is currently underway at Clinical Pharmacology of Miami. It is designed to further evaluate the safety, tolerability and pharmacokinetics of multiple-ascending

Remodulin Injection is indicated to treat patients with pulmonary arterial hypertension (PAH) via a pre-filled semi-disposable pump system. The company intends to launch the new subcutaneous Remodulin delivery

Inhalation of a non-sterile product with microbial contamination into the airways could increase the risk of respiratory infection. The risk is higher in patients who are immunocompromised (because

Tekmira today reported that: Enrolment of the target patient numbers in these Phase I/II studies has been completed; To date, 55 patients, in the both the Phase I